Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» anifrolumab
anifrolumab
AstraZeneca lupus drug shows potential, but it may not be enough for FDA
Biopharma Dive
Thu, 12/19/19 - 01:05 pm
AstraZeneca
lupus
anifrolumab
GSK
Benlysta
AstraZeneca plans 2020 filing for anifrolumab in lupus
Fierce Biotech
Tue, 11/12/19 - 10:25 am
AstraZeneca
FDA
lupus
anifrolumab
One year after flop, AstraZeneca's phase 3 lupus trial hits endpoint
Fierce Biotech
Thu, 08/29/19 - 10:30 am
AstraZeneca
clinical trials
anifrolumab
systemic lupus erythematosus
lupus
Another setback for AstraZeneca as lupus drug fails phase 3 test
Fierce Biotech
Fri, 08/31/18 - 11:43 am
AstraZeneca
SLE
systemic lupus erythematosus
lupus
anifrolumab
clinical trials
AstraZeneca may have a lupus blockbuster-in-waiting
BioPharma Dive
Wed, 11/11/15 - 09:29 pm
lupus
AstraZeneca
anifrolumab